Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global epigenetics market stood at a value of around USD 1,285.68 million in 2023. The market is further expected to grow at a CAGR of 13.8% in the forecast period of 2024-2032 to attain a value of USD 4,100.62 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the kits segment holds a significant share in the global epigenetics industry. This growth can be attributed to the important role of kits in the entire epigenetic analysis process. Furthermore, this number is further expected to rise in the forecast period due to the increasing chronic illnesses and the growing geriatric population rates, which is very susceptible to acquiring various diseases, including cardiovascular diseases or cancer. Meanwhile, the oncology segment is estimated to observe a healthy growth in terms of application due to the high usage of epigenetic research in the oncology field.
North America is predicted to occupy a considerable share of the global epigenetics industry. This surge can be attributed to the increased utilisation of epigenetic research in the region and the increased investments in the development of the healthcare sector. Another factor influencing the market growth is the rising geriatric population in the region, who are susceptible to chronic diseases such as Parkinson’s disease and cancer.
Epigenetics is an emerging scientific area of study that analyses how environmental influences impact the expression of genes. Based on different environmental experiences, genes are activated and deactivated by cells without any change in the underlying DNA structure of the organism and predict which proteins are transcribed. These external environmental stimuli can affect the genes, which could influence diseases. In addition, research has indicated that many human diseases occur due to the interaction between genetic variants and environmental exposure, such as autism, Parkinson’s disease, and breast cancer, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is divided into:
Kits are further divided by type into ChIP sequencing kits, bisulfite conversion kits, whole genome amplification kits, 5-hmC & 5-mC analysis kits, and RNA sequencing kits, among others. At the same time, reagents are further segmented by type into antibodies, magnetic beads, histones, buffers, primers, and others. Meanwhile, enzymes are categorised by type into DNA polymerases, DNA ligases, methyltransferases, acetylases, and reverse transcriptase, among others. And instruments are segregated by type into next-generation sequencers, qPCRs, mass spectrometers, sonicators, and others.
On the basis of application, the industry can be categorised into:
Oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is segmented by type into metabolic diseases, infectious diseases, inflammatory diseases, cardiovascular diseases, and others.
Based on end use, the market can be segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
According to WHO reports, cardiovascular diseases are the leading cause of death globally, claiming more than 17.9 million lives every year. Cardiovascular diseases are illnesses of heart and blood vessels that are adversely affected by high-risk behaviours such as unhealthy diet, physical inactivity, and substance abuse. In this regard, epigenetic research has found epigenetic biomarkers, a promising tool for the diagnosis and prognosis of many cardiovascular diseases. Some of their promising features include easy accessibility and feasibility in their detection methods, making them applicable for use in clinical interventions. This is significantly contributing to the growth of the market.
In a 2017 research by the American Diabetes Association, the researchers concluded that diabetes is a complication developed from the interaction of DNA structure variation and the environmental stimuli that causes changes in the cellular phenotype.
The report gives a detailed analysis of the following key players in the global epigenetics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End Use |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the global epigenetics market attained a value of nearly USD 1,285.68 million.
The market is projected to grow at a CAGR of 13.8% between 2024 and 2032.
The major drivers of the industry such as increased investment in the research and development of epigenetic interventions, increasing chronic illnesses, increased application of epigenetic analysis mechanisms in the oncology field, and rising ageing population globally are expected to aid the market growth.
The key market trends guiding the industry's growth include the increasing incidences of cardiovascular diseases and increased utilisation of epigenetic research.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant product segments can be divided into kits, reagents, enzymes, and instruments.
The significant applications of the product include oncology and non-oncology. The oncology segment is further divided by type into solid tumours and liquid tumours, whereas non-oncology is distributed by type into metabolic disease, infectious diseases, inflammatory diseases, and cardiovascular diseases, among others.
The major segments based on end-use include academics and research institutes, pharmaceutical and biotechnology companies, and contract research organisations.
The major players in the industry are Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., and QIAGEN GmbH, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share